COMPANY OVERVIEW

Nohla Therapeutics is pioneering new universal donor expanded cord blood therapies to save lives.

---

LOCATION

Seattle, WA, USA

---

THERAPEUTIC AREAS

Hematology

Immunology

Oncology

---

WEBSITE

https://nohlatherapeutics.com

---

CAREER WEBSITE

https://nohlatherapeutics.com/careers/

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Jun 27, 2019

Global Cancer Stem Cell Therapeutics Market to 2023 - Led by Cellerant Therapeutics, Celularity, Gamida Cell, Nohla Therapeutics, and Sumitomo Dainippon Pharma Co

Aug 6, 2018

Nohla Therapeutics Receives FDA Fast Track Designation for Dilanubicel for Allogeneic Cord Blood Transplant Patients

Jul 30, 2018

Nohla Therapeutics Announces Hiring of Dr. Sarah Noonberg as Chief Medical Officer and Appointment of Dr. Colleen Delaney as Chief Scientific Officer

Jul 16, 2018

Nohla Therapeutics Receives FDA Orphan Drug Designation for Dilanubicel for Hematopoietic Stem Cell Transplant Patients

Jul 11, 2018

Nohla Therapeutics Announces Second Closing of $56 Million Series B Financing

For More Press Releases

---